Literature DB >> 18266069

Successful steroid treatment in a patient with membranoproliferative glomerulonephritis associated with hepatitis C virus.

Toru Sanai1, Izumi Watanabe, Tadashi Hirano, Masaru Nakayama, Hironori Sakai, Noriko Uesugi, Kohsuke Masutani, Ritsuko Katafuchi, Hideki Hirakata, Mitsuo Iida.   

Abstract

Thirteen years ago, a 65-year-old woman was diagnosed to have chronic active hepatitis with hepatitis C virus. After starting interferon alpha administration, she noticed edema and hypoalbuminemia. Renal biopsy revealed mesangial proliferation with focal endocapillary proliferation, and double contour of the glomerular basement membrane due to mesangial interposition. Interferon alpha was discontinued, and proteinuria and edema gradually decreased. She was re-admitted due to a relapse of proteinuria 8 years later. Biopsy revealed moderate mesangial and endcapillary proliferation presenting a lobular pattern, in addition to the presence of hyaline thrombi. Granular staining of immunoglobulin M and of C3 in capillary walls were detected. Since cryoglobulinemia was positive, a final diagnosis of cryoglobulinemic membranoproliferative glomerulonephritis was made. Prednisolone was started with an initial dose of 20 mg/day. Proteinuria and hypoalbuminemia improved, and prednisolone was tapered to 5 mg/day 9 months after the 2nd renal biopsy. The hepatitis C virus-RNA titer fluctuated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266069     DOI: 10.1007/s11255-007-9322-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

1.  Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.

Authors:  G Garini; L Allegri; L Carnevali; W Catellani; P Manganelli; C Buzio
Journal:  Am J Kidney Dis       Date:  2001-12       Impact factor: 8.860

2.  Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides.

Authors:  S D Averbuch; H A Austin; S A Sherwin; T Antonovych; P A Bunn; D L Longo
Journal:  N Engl J Med       Date:  1984-01-05       Impact factor: 91.245

Review 3.  Therapeutic plasma exchange in renal diseases.

Authors:  F Madore; J M Lazarus; H R Brady
Journal:  J Am Soc Nephrol       Date:  1996-03       Impact factor: 10.121

4.  Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus.

Authors:  Edmundo P A Lopes; Lucila M Valente; A Eduardo B Silva; Gianna Mastroianni Kirsztajn; Cibele N Cruz; Maria Lucia G Ferraz
Journal:  Braz J Infect Dis       Date:  2003-10       Impact factor: 1.949

5.  Clinicopathological analysis and therapy in hepatitis C virus-associated nephropathy.

Authors:  A Komatsuda; H Imai; H Wakui; K Hamai; H Ohtani; T Kodama; Y Oyama; A B Miura; Y Nakamoto
Journal:  Intern Med       Date:  1996-07       Impact factor: 1.271

6.  Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan.

Authors:  H Yamabe; R J Johnson; D R Gretch; K Fukushi; H Osawa; M Miyata; H Inuma; T Sasaki; M Kaizuka; N Tamura
Journal:  J Am Soc Nephrol       Date:  1995-08       Impact factor: 10.121

7.  Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.

Authors:  T L Fong; B Valinluck; S Govindarajan; F Charboneau; R H Adkins; A G Redeker
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

8.  Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy.

Authors:  R J Johnson; D R Gretch; W G Couser; C E Alpers; J Wilson; M Chung; J Hart; R Willson
Journal:  Kidney Int       Date:  1994-12       Impact factor: 10.612

9.  Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection.

Authors:  R J Quigg; M Brathwaite; D F Gardner; D R Gretch; S Ruddy
Journal:  Am J Kidney Dis       Date:  1995-05       Impact factor: 8.860

10.  HCV-marker-positive autoimmune-type chronic active hepatitis: a possible relation between HCV infection and liver autoreaction.

Authors:  M Zeniya; Y Aizawa; F Watanabe; T Kawabe; M Hara; M Sakaguchi; G Toda
Journal:  Liver       Date:  1994-08
View more
  1 in total

1.  Hepatitis C virus-related glomerulonephritis with acute kidney injury requiring hemodialysis that improved with virus removal and eradication using double-filtration plasmapheresis without interferon.

Authors:  Akiko Morisue; Kosuke Fukuoka; Ruiko Goto; Kosuke Ota; Haruhiro Yamashita; Yoko Shinno; Ichiro Yamadori
Journal:  CEN Case Rep       Date:  2014-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.